Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects

Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determi...

Full description

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 204; no. 2; pp. 509 - 514
Main Authors Rajendran, Sharmalar, Willoughby, Scott R., Chan, Wai Ping A., Liberts, Elizabeth A., Heresztyn, Tamila, Saha, Mrinal, Marber, Michael S., Norman, Robert J., Horowitz, John D.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ireland Ltd 01.06.2009
Elsevier
Subjects
Online AccessGet full text
ISSN0021-9150
1879-1484
1879-1484
DOI10.1016/j.atherosclerosis.2008.09.010

Cover

Abstract Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1 ± 1.3) were evaluated in lean ( n = 12) and obese ( n = 12) subgroups, and compared with age-matched lean normals ( n = 12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N G , N G -dimethyl- l-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired ( P < 0.01 for both), as were their endothelium-dependent vascular responses to salbutamol ( P < 0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P < 0.05). Impairment of SNP response remained unaltered after mean 30 ± 2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance.
AbstractList Abstract Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1 ± 1.3) were evaluated in lean ( n = 12) and obese ( n = 12) subgroups, and compared with age-matched lean normals ( n = 12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N G , N G -dimethyl- l -arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired ( P < 0.01 for both), as were their endothelium-dependent vascular responses to salbutamol ( P < 0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P < 0.05). Impairment of SNP response remained unaltered after mean 30 ± 2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance.
Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1+/-1.3) were evaluated in lean (n=12) and obese (n=12) subgroups, and compared with age-matched lean normals (n=12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N(G),N(G)-dimethyl-L-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired (P<0.01 for both), as were their endothelium-dependent vascular responses to salbutamol (P<0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P<0.05). Impairment of SNP response remained unaltered after mean 30+/-2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance.Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1+/-1.3) were evaluated in lean (n=12) and obese (n=12) subgroups, and compared with age-matched lean normals (n=12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N(G),N(G)-dimethyl-L-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired (P<0.01 for both), as were their endothelium-dependent vascular responses to salbutamol (P<0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P<0.05). Impairment of SNP response remained unaltered after mean 30+/-2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance.
Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1 ± 1.3) were evaluated in lean ( n = 12) and obese ( n = 12) subgroups, and compared with age-matched lean normals ( n = 12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N G , N G -dimethyl- l-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired ( P < 0.01 for both), as were their endothelium-dependent vascular responses to salbutamol ( P < 0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P < 0.05). Impairment of SNP response remained unaltered after mean 30 ± 2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance.
Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk factors, often co-exists with endothelial dysfunction and represents an independent marker of long-term cardiovascular risk. We sought to determine whether polycystic ovary syndrome (PCOS), which has been postulated as a cardiovascular risk factor in women, is independently associated with this phenomenon. Twenty-four young women with PCOS (mean age 32.1+/-1.3) were evaluated in lean (n=12) and obese (n=12) subgroups, and compared with age-matched lean normals (n=12). Platelet aggregation and its inhibition by the nitric oxide donor sodium nitroprusside (SNP) were assessed and compared with vascular endothelial function. Plasma concentrations of malondialdehyde (MDA), N(G),N(G)-dimethyl-L-arginine (ADMA) and hs-CRP were measured as markers of oxidative stress, endothelial dysfunction and inflammation, respectively. Circulating endothelial progenitor cell (EPC) counts were also documented. In both PCOS subgroups, which demonstrated hyperaggregability to ADP, responses to SNP inhibition of aggregation (the principal end-point of the study) were significantly impaired (P<0.01 for both), as were their endothelium-dependent vascular responses to salbutamol (P<0.05 for both). However, vasomotor responses to nitroglycerin and circulating EPC counts did not vary between groups. PCOS subjects also had significantly elevated ADMA, MDA and hs-CRP levels relative to normals (all P<0.05). Impairment of SNP response remained unaltered after mean 30+/-2.4 months follow-up in PCOS subjects. We conclude that in PCOS subjects, independent of obesity and associated insulin resistance, profound and reproducible impairment of platelet responsiveness to NO is an additional component of cardiovascular homeostatic disturbance.
Author Chan, Wai Ping A.
Willoughby, Scott R.
Norman, Robert J.
Horowitz, John D.
Liberts, Elizabeth A.
Rajendran, Sharmalar
Heresztyn, Tamila
Saha, Mrinal
Marber, Michael S.
Author_xml – sequence: 1
  givenname: Sharmalar
  surname: Rajendran
  fullname: Rajendran, Sharmalar
  organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia
– sequence: 2
  givenname: Scott R.
  surname: Willoughby
  fullname: Willoughby, Scott R.
  organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia
– sequence: 3
  givenname: Wai Ping A.
  surname: Chan
  fullname: Chan, Wai Ping A.
  organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia
– sequence: 4
  givenname: Elizabeth A.
  surname: Liberts
  fullname: Liberts, Elizabeth A.
  organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia
– sequence: 5
  givenname: Tamila
  surname: Heresztyn
  fullname: Heresztyn, Tamila
  organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia
– sequence: 6
  givenname: Mrinal
  surname: Saha
  fullname: Saha, Mrinal
  organization: Cardiovascular Division, Kings College London, The Rayne Institute, St. Thomas’ Hospital, United Kingdom
– sequence: 7
  givenname: Michael S.
  surname: Marber
  fullname: Marber, Michael S.
  organization: Cardiovascular Division, Kings College London, The Rayne Institute, St. Thomas’ Hospital, United Kingdom
– sequence: 8
  givenname: Robert J.
  surname: Norman
  fullname: Norman, Robert J.
  organization: Research Centre for Reproductive Health, The Queen Elizabeth Hospital, Department of Obstetrics and Gynaecology, The University of Adelaide, Australia
– sequence: 9
  givenname: John D.
  surname: Horowitz
  fullname: Horowitz, John D.
  email: john.horowitz@adelaide.edu.au
  organization: Cardiology Unit, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21630308$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19027116$$D View this record in MEDLINE/PubMed
BookMark eNqVkl1rFDEUhoNU7Lb6FyQ39W7Xk_meCwVZalsoKKjXIZM5Q7NmkzUnszr_3oy7KiwI9SYDmec8HN43F-zMeYeMXQlYCRDV681KxQcMnrSdT0OrDKBZQbsCAU_YQjR1uxRFU5yxBUAmlq0o4ZxdEG0AoKhF84ydixayWohqwX589HbSE0Wjud-rMHGaXB_8Frkhroi8Nipiz7-b-MAJ9xiQ72y6shi5cj1H1_u0kTXK8n6iYXQ6Gu-4cbxLP7jvkPAXaVE5TmO3QR3pOXs6KEv44vi9ZF_eX39e3y7vP9zcrd_dL3WZF3Gp8rQx5sMghlKVSgwdVl3bDjWKTBddleeiKbFoawXFkPKBqsq7rhRVo5u-Ger8kr06eHfBfxuRotwa0mitcuhHklWdtWWaT-DLIzh2W-zlLphtykP-zioBV0dAkVZ2CMppQ3-4LCGQQ5O4NwdOp34o4PBXBXLuUG7kSYdy7lBCK1OHaX59Mq9NVHOmMShjH225OVgwhbs3GCRpg05jb0LKX_bePNr09sSkrXEmRfAVJ6SNH4NLDUohKZMgP82vbn500ABUWSuS4Prfgv9Y5CcSUPUa
CitedBy_id crossref_primary_10_1007_s10815_014_0190_7
crossref_primary_10_3109_09513590_2010_551566
crossref_primary_10_1155_2011_402052
crossref_primary_10_1177_1933719115570900
crossref_primary_10_1186_s12967_021_02897_0
crossref_primary_10_1016_j_pharmthera_2009_08_001
crossref_primary_10_3109_09513590_2010_507291
crossref_primary_10_1111_cen_12447
crossref_primary_10_33667_2078_5631_2019_1_1_376__53_58
crossref_primary_10_4103_0256_4947_65255
crossref_primary_10_1016_j_clnu_2014_09_015
crossref_primary_10_1002_jbm_a_37669
crossref_primary_10_1007_s10557_013_6481_x
crossref_primary_10_1007_s12020_011_9461_6
crossref_primary_10_1007_s12011_018_1602_9
crossref_primary_10_1160_TH14_09_0797
crossref_primary_10_1080_0167482X_2018_1557144
crossref_primary_10_3892_etm_2011_327
crossref_primary_10_1016_j_fertnstert_2012_10_013
crossref_primary_10_1093_humupd_dmr025
crossref_primary_10_1080_01443615_2019_1603215
crossref_primary_10_17795_semj21893
crossref_primary_10_1016_j_rbmo_2011_10_010
crossref_primary_10_21070_acopen_8_2023_7830
crossref_primary_10_1097_GCO_0000000000000619
crossref_primary_10_1007_s00404_012_2358_7
crossref_primary_10_1530_EJE_11_0755
crossref_primary_10_3390_ijms23031042
crossref_primary_10_1016_j_tcm_2012_01_001
crossref_primary_10_1016_j_jacc_2012_01_066
crossref_primary_10_1016_j_mce_2010_08_002
crossref_primary_10_1111_j_1365_2265_2009_03598_x
crossref_primary_10_1177_0003319709361198
crossref_primary_10_1007_s43032_022_01030_w
crossref_primary_10_1186_s12902_015_0005_6
crossref_primary_10_1016_j_ejogrb_2015_05_005
crossref_primary_10_1016_j_amjmed_2014_11_007
crossref_primary_10_3389_fendo_2023_1172750
crossref_primary_10_2217_clp_09_55
crossref_primary_10_3892_ijmm_2017_3146
crossref_primary_10_1210_jc_2010_2279
crossref_primary_10_1097_SMJ_0b013e31820c0172
crossref_primary_10_1016_j_orcp_2009_08_001
crossref_primary_10_31832_smj_855493
crossref_primary_10_1371_journal_pone_0020317
crossref_primary_10_4103_ijmr_IJMR_1899_17
crossref_primary_10_1016_j_fertnstert_2010_06_058
crossref_primary_10_1093_humrep_des138
crossref_primary_10_1136_heartjnl_2014_305509
crossref_primary_10_1186_1477_7827_12_25
crossref_primary_10_1007_s10557_016_6671_4
crossref_primary_10_1155_2012_317241
crossref_primary_10_1016_j_amjmed_2012_12_015
crossref_primary_10_1016_j_gene_2017_11_049
crossref_primary_10_1016_j_phrs_2017_01_011
crossref_primary_10_1016_j_fertnstert_2010_03_049
crossref_primary_10_1210_er_2012_1003
crossref_primary_10_1016_j_niox_2011_06_005
crossref_primary_10_1007_s12020_019_02059_9
crossref_primary_10_1093_humupd_dms059
crossref_primary_10_1371_journal_pone_0247049
crossref_primary_10_1016_j_fertnstert_2010_11_036
crossref_primary_10_1592_phco_30_5_442
crossref_primary_10_1016_j_fertnstert_2010_08_030
crossref_primary_10_1016_j_ajpath_2023_08_008
crossref_primary_10_1111_cen_12137
crossref_primary_10_1016_j_tem_2019_01_005
crossref_primary_10_3109_09513590_2012_706667
crossref_primary_10_1016_j_atherosclerosis_2015_07_017
crossref_primary_10_1016_j_metabol_2018_10_008
crossref_primary_10_4137_CMWH_S9721
crossref_primary_10_1155_2015_786362
crossref_primary_10_1016_j_metabol_2015_08_010
Cites_doi 10.1161/hh1301.093953
10.1016/j.ejogrb.2006.09.009
10.1093/humrep/deh098
10.1210/jc.2005-0151
10.1007/BF00280883
10.1161/hq0102.101770
10.1016/S0015-0282(16)58687-7
10.1210/jc.2003-031867
10.1210/er.2003-0004
10.1210/jc.2007-0842
10.1111/j.1365-2362.2006.01712.x
10.1210/jc.2004-1045
10.1016/j.pharmthera.2007.06.012
10.1136/jcp.2003.015271
10.1161/01.ATV.0000193622.77294.57
10.1111/j.1365-2265.2006.02645.x
10.1016/S0076-6879(84)05038-2
10.1161/01.CIR.103.10.1410
10.1210/jc.85.5.1851
10.1097/01.ogx.0000156089.26363.5b
10.1093/humrep/16.12.2606
10.1161/01.CIR.102.23.2810
10.1097/00001703-200106000-00013
10.1016/S0735-1097(01)01238-4
10.1161/01.CIR.100.2.129
10.1016/S0735-1097(02)01991-5
10.1161/01.CIR.101.16.1899
10.1111/j.1471-0528.2006.01090.x
10.1161/01.CIR.0000111245.75752.C6
10.1179/135100004225005219
10.1056/NEJMra041536
10.1016/j.jacc.2006.08.053
10.1016/j.jacc.2005.04.066
10.1007/s00395-007-0680-1
10.1210/jc.84.1.165
10.1016/j.jchromb.2004.03.020
10.1210/jc.85.7.2402
10.1210/jc.2002-021391
ContentType Journal Article
Copyright 2008 Elsevier Ireland Ltd
Elsevier Ireland Ltd
2009 INIST-CNRS
Copyright_xml – notice: 2008 Elsevier Ireland Ltd
– notice: Elsevier Ireland Ltd
– notice: 2009 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.atherosclerosis.2008.09.010
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1484
EndPage 514
ExternalDocumentID 19027116
21630308
10_1016_j_atherosclerosis_2008_09_010
S0021915008006291
1_s2_0_S0021915008006291
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M27
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OK1
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
WUQ
X7M
Z5R
ZGI
ZXP
~G-
~KM
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
NCXOZ
RIG
0SF
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
ACLOT
CITATION
~HD
AGRNS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c534t-a3718e3ff1f5a5a1fbe6b99f7e12c4b633185e497a04f0160663bb5168c8d8f73
IEDL.DBID .~1
ISSN 0021-9150
1879-1484
IngestDate Sat Sep 27 19:42:29 EDT 2025
Mon Jul 21 06:05:42 EDT 2025
Mon Jul 21 09:16:59 EDT 2025
Wed Oct 01 04:59:50 EDT 2025
Thu Apr 24 23:10:41 EDT 2025
Fri Feb 23 02:28:05 EST 2024
Sun Feb 23 10:19:14 EST 2025
Tue Aug 26 17:43:42 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Polycystic ovary syndrome
Endothelial function
Platelets
Nitric oxide
Human
Obesity
Nutrition disorder
Female sterility
Cardiovascular disease
Polycystic ovary
Female genital diseases
Thrombocytopathy
Vascular disease
Ovarian diseases
Platelet
Cyst
Atherosclerosis
Endothelial dysfunction
Benign neoplasm
Nutritional status
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c534t-a3718e3ff1f5a5a1fbe6b99f7e12c4b633185e497a04f0160663bb5168c8d8f73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 19027116
PQID 67295497
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_67295497
pubmed_primary_19027116
pascalfrancis_primary_21630308
crossref_primary_10_1016_j_atherosclerosis_2008_09_010
crossref_citationtrail_10_1016_j_atherosclerosis_2008_09_010
elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2008_09_010
elsevier_clinicalkeyesjournals_1_s2_0_S0021915008006291
elsevier_clinicalkey_doi_10_1016_j_atherosclerosis_2008_09_010
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-06-01
PublicationDateYYYYMMDD 2009-06-01
PublicationDate_xml – month: 06
  year: 2009
  text: 2009-06-01
  day: 01
PublicationDecade 2000
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Ireland
PublicationTitle Atherosclerosis
PublicationTitleAlternate Atherosclerosis
PublicationYear 2009
Publisher Elsevier Ireland Ltd
Elsevier
Publisher_xml – name: Elsevier Ireland Ltd
– name: Elsevier
References Vasa, Fichtlscherer, Aicher (bib20) 2001; 89
Bickerton, Clark, Meeking (bib34) 2005; 58
Legro, Kunselman, Dodson, Dunaif (bib7) 1999; 84
Bird, Draper (bib22) 1984; 105
Heresztyn, Worthley, Horowitz (bib19) 2004; 805
Kravariti, Naka, Kalantaridou (bib12) 2005; 90
Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (bib27) 1985; 28
Heutling, Schulz, Nickel (bib14) 2008; 93
Dereli, Ozgen, Buyukkececi, Guney, Yilmaz (bib15) 2003; 88
Nacul, Andrade, Schwarz, Homem de Bittencourt, Spritzer (bib13) 2007; 133
(bib3) 2004; 19
Thum, Tsikas, Stein (bib37) 2005; 46
Apridonidze, Essah, Iuorno, Nestler (bib6) 2005; 90
Ehrmann (bib1) 2005; 352
Chirkov, Holmes, Willoughby (bib29) 2001; 37
Orio, Palomba, Cascella (bib10) 2004; 89
Diamanti-Kandrakis, Alexandraki, Piperi (bib31) 2006; 36
Brinkworth, Noakes, Moran, Norman, Clifton (bib35) 2006; 113
Willoughby, Stewart, Holmes, Chirkov, Horowitz (bib18) 2005; 25
Wilkinson, Hall, MacCallum (bib24) 2002; 22
Werner, Wassmann, Ahlers (bib38) 2007; 102
Legro (bib39) 2003; 24
Chirkov, Holmes, Chirkova, Horowitz (bib23) 1999; 100
Dunaif, Hoffman, Scully (bib5) 1985; 66
Sorensen, Franks, Robertson, Pennell, Collins (bib32) 2006; 65
Tarkun, Arslan, Canturk, Turemen, Sahin, Duman (bib11) 2005; 60
Paradisi, Steinberg, Hempfling (bib9) 2001; 103
Katz, Nambi, Mather (bib28) 2000; 85
Hayward, Kraidly, Webb, Collins (bib25) 2002; 40
Chirkov, Horowitz (bib16) 2007; 116
Schächinger, Britten, Zeiher (bib17) 2000; 101
Grundy (bib26) 2004; 109
Mather, Verma, Corenblum, Anderson (bib33) 2000; 85
Worthley, Holmes, Willoughby (bib30) 2007; 49
Sage, de la Lande, Stafford (bib36) 2000; 102
Norman (bib8) 2001; 13
Norman, Masters, Hague (bib4) 1996; 66
Wang, Davies, Norman (bib2) 2001; 16
Rahman, Biswas (bib21) 2004; 9
Paradisi (10.1016/j.atherosclerosis.2008.09.010_bib9) 2001; 103
Willoughby (10.1016/j.atherosclerosis.2008.09.010_bib18) 2005; 25
Grundy (10.1016/j.atherosclerosis.2008.09.010_bib26) 2004; 109
Apridonidze (10.1016/j.atherosclerosis.2008.09.010_bib6) 2005; 90
Heutling (10.1016/j.atherosclerosis.2008.09.010_bib14) 2008; 93
Wilkinson (10.1016/j.atherosclerosis.2008.09.010_bib24) 2002; 22
Katz (10.1016/j.atherosclerosis.2008.09.010_bib28) 2000; 85
Rahman (10.1016/j.atherosclerosis.2008.09.010_bib21) 2004; 9
Dereli (10.1016/j.atherosclerosis.2008.09.010_bib15) 2003; 88
Hayward (10.1016/j.atherosclerosis.2008.09.010_bib25) 2002; 40
Werner (10.1016/j.atherosclerosis.2008.09.010_bib38) 2007; 102
Chirkov (10.1016/j.atherosclerosis.2008.09.010_bib16) 2007; 116
Orio (10.1016/j.atherosclerosis.2008.09.010_bib10) 2004; 89
Wang (10.1016/j.atherosclerosis.2008.09.010_bib2) 2001; 16
Vasa (10.1016/j.atherosclerosis.2008.09.010_bib20) 2001; 89
Sorensen (10.1016/j.atherosclerosis.2008.09.010_bib32) 2006; 65
(10.1016/j.atherosclerosis.2008.09.010_bib3) 2004; 19
Norman (10.1016/j.atherosclerosis.2008.09.010_bib8) 2001; 13
Sage (10.1016/j.atherosclerosis.2008.09.010_bib36) 2000; 102
Bird (10.1016/j.atherosclerosis.2008.09.010_bib22) 1984; 105
Schächinger (10.1016/j.atherosclerosis.2008.09.010_bib17) 2000; 101
Chirkov (10.1016/j.atherosclerosis.2008.09.010_bib29) 2001; 37
Legro (10.1016/j.atherosclerosis.2008.09.010_bib7) 1999; 84
Nacul (10.1016/j.atherosclerosis.2008.09.010_bib13) 2007; 133
Mather (10.1016/j.atherosclerosis.2008.09.010_bib33) 2000; 85
Matthews (10.1016/j.atherosclerosis.2008.09.010_bib27) 1985; 28
Legro (10.1016/j.atherosclerosis.2008.09.010_bib39) 2003; 24
Kravariti (10.1016/j.atherosclerosis.2008.09.010_bib12) 2005; 90
Ehrmann (10.1016/j.atherosclerosis.2008.09.010_bib1) 2005; 352
Chirkov (10.1016/j.atherosclerosis.2008.09.010_bib23) 1999; 100
Brinkworth (10.1016/j.atherosclerosis.2008.09.010_bib35) 2006; 113
Thum (10.1016/j.atherosclerosis.2008.09.010_bib37) 2005; 46
Norman (10.1016/j.atherosclerosis.2008.09.010_bib4) 1996; 66
Bickerton (10.1016/j.atherosclerosis.2008.09.010_bib34) 2005; 58
Dunaif (10.1016/j.atherosclerosis.2008.09.010_bib5) 1985; 66
Worthley (10.1016/j.atherosclerosis.2008.09.010_bib30) 2007; 49
Diamanti-Kandrakis (10.1016/j.atherosclerosis.2008.09.010_bib31) 2006; 36
Tarkun (10.1016/j.atherosclerosis.2008.09.010_bib11) 2005; 60
Heresztyn (10.1016/j.atherosclerosis.2008.09.010_bib19) 2004; 805
References_xml – volume: 60
  start-page: 180
  year: 2005
  end-page: 181
  ident: bib11
  article-title: Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation
  publication-title: Obstet Gynecol Surv
– volume: 113
  start-page: 1308
  year: 2006
  end-page: 1314
  ident: bib35
  article-title: Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome
  publication-title: BJOG
– volume: 16
  start-page: 2606
  year: 2001
  end-page: 2609
  ident: bib2
  article-title: Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment
  publication-title: Hum Reprod
– volume: 36
  start-page: 691
  year: 2006
  end-page: 697
  ident: bib31
  article-title: Inflammatory and endothelial markers in women with polycystic ovary syndrome
  publication-title: Eur J Clin Invest
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  ident: bib27
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
– volume: 37
  start-page: 1851
  year: 2001
  end-page: 1857
  ident: bib29
  article-title: Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets
  publication-title: J Am Coll Cardiol
– volume: 100
  start-page: 129
  year: 1999
  end-page: 134
  ident: bib23
  article-title: Nitrate resistance in platelets from patients with stable angina pectoris
  publication-title: Circulation
– volume: 65
  start-page: 655
  year: 2006
  end-page: 659
  ident: bib32
  article-title: Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors
  publication-title: Clin Endocrinol
– volume: 66
  start-page: 942
  year: 1996
  end-page: 947
  ident: bib4
  article-title: Hyperinsulinemia is common in family members of women with polycystic ovary syndrome
  publication-title: Fertil Steril
– volume: 90
  start-page: 5088
  year: 2005
  end-page: 5095
  ident: bib12
  article-title: Predictors of endothelial dysfunction in young women with polycystic ovary
  publication-title: J Clin Endocrinol Metab
– volume: 46
  start-page: 1693
  year: 2005
  end-page: 1701
  ident: bib37
  article-title: Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine
  publication-title: J Am Coll Cardiol
– volume: 102
  start-page: 2810
  year: 2000
  end-page: 2815
  ident: bib36
  article-title: Nitroglycerin tolerance in human vessels. Evidence for impaired nitroglycerin bioconversion
  publication-title: Circulation
– volume: 24
  start-page: 302
  year: 2003
  end-page: 312
  ident: bib39
  article-title: Polycystic ovary syndrome and cardiovascular disease: a premature association?
  publication-title: Endocr Rev
– volume: 25
  start-page: 2661
  year: 2005
  end-page: 2666
  ident: bib18
  article-title: Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 49
  start-page: 304
  year: 2007
  end-page: 310
  ident: bib30
  article-title: The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes. Mediation by superoxide production, resolution with intensive insulin administration
  publication-title: J Am Coll Cardiol
– volume: 84
  start-page: 165
  year: 1999
  end-page: 169
  ident: bib7
  article-title: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women
  publication-title: J Clin Endocrinol Metab
– volume: 9
  start-page: 125
  year: 2004
  end-page: 143
  ident: bib21
  article-title: Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues
  publication-title: Redox Rep
– volume: 58
  start-page: 151
  year: 2005
  end-page: 154
  ident: bib34
  article-title: Cardiovascular risk in women with polycystic ovary syndrome (PCOS)
  publication-title: J Clin Pathol
– volume: 85
  start-page: 2402
  year: 2000
  end-page: 2410
  ident: bib28
  article-title: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans
  publication-title: J Clin Endocrinol Metab
– volume: 89
  start-page: 4588
  year: 2004
  end-page: 4593
  ident: bib10
  article-title: Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome
  publication-title: J Clin Endocrinol Metab
– volume: 805
  start-page: 325
  year: 2004
  end-page: 329
  ident: bib19
  article-title: Determination of
  publication-title: J Chromatogr B
– volume: 40
  start-page: 521
  year: 2002
  end-page: 528
  ident: bib25
  article-title: Assessment of endothelial function using peripheral waveform analysis: a clinical application
  publication-title: J Am Coll Cardiol
– volume: 13
  start-page: 323
  year: 2001
  end-page: 327
  ident: bib8
  article-title: Obesity, polycystic ovary syndrome and anovulation—how are they interrelated?
  publication-title: Curr Opin Obstet Gynecol
– volume: 93
  start-page: 82
  year: 2008
  end-page: 90
  ident: bib14
  article-title: Asymmetric dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment
  publication-title: J Clin Endocrinol Metab
– volume: 109
  start-page: 433
  year: 2004
  end-page: 438
  ident: bib26
  article-title: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition
  publication-title: Circulation
– volume: 352
  start-page: 1223
  year: 2005
  end-page: 1236
  ident: bib1
  article-title: Polycystic ovary syndrome
  publication-title: N Engl J Med
– volume: 19
  start-page: 41
  year: 2004
  end-page: 47
  ident: bib3
  article-title: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
  publication-title: Hum Reprod
– volume: 90
  start-page: 1929
  year: 2005
  end-page: 1935
  ident: bib6
  article-title: Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
  publication-title: J Clin Endocrinol Metab
– volume: 66
  start-page: 545
  year: 1985
  end-page: 552
  ident: bib5
  article-title: Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization
  publication-title: Obstet Gynecol
– volume: 133
  start-page: 191
  year: 2007
  end-page: 196
  ident: bib13
  article-title: Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity
  publication-title: Eur J Obstet Gynecol Reprod Biol
– volume: 105
  start-page: 299
  year: 1984
  end-page: 305
  ident: bib22
  article-title: Comparative studies on different methods of malonaldehyde determination
  publication-title: Methods Enzymol
– volume: 103
  start-page: 1410
  year: 2001
  end-page: 1415
  ident: bib9
  article-title: Polycystic ovary syndrome is associated with endothelial dysfunction
  publication-title: Circulation
– volume: 89
  start-page: E1
  year: 2001
  end-page: E7
  ident: bib20
  article-title: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease
  publication-title: Circ Res
– volume: 101
  start-page: 1899
  year: 2000
  end-page: 1906
  ident: bib17
  article-title: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
  publication-title: Circulation
– volume: 102
  start-page: 565
  year: 2007
  end-page: 571
  ident: bib38
  article-title: Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease
  publication-title: Basic Res Cardiol
– volume: 116
  start-page: 287
  year: 2007
  end-page: 305
  ident: bib16
  article-title: Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier
  publication-title: Pharmacol Ther
– volume: 22
  start-page: 147
  year: 2002
  end-page: 152
  ident: bib24
  article-title: Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 88
  start-page: 2263
  year: 2003
  end-page: 2268
  ident: bib15
  article-title: Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity
  publication-title: J Clin Endocrinol Metab
– volume: 85
  start-page: 1851
  year: 2000
  end-page: 1856
  ident: bib33
  article-title: Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome
  publication-title: J Clin Endocrinol Metab
– volume: 89
  start-page: E1
  year: 2001
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib20
  article-title: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease
  publication-title: Circ Res
  doi: 10.1161/hh1301.093953
– volume: 133
  start-page: 191
  year: 2007
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib13
  article-title: Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity
  publication-title: Eur J Obstet Gynecol Reprod Biol
  doi: 10.1016/j.ejogrb.2006.09.009
– volume: 19
  start-page: 41
  year: 2004
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib3
  article-title: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
  publication-title: Hum Reprod
  doi: 10.1093/humrep/deh098
– volume: 90
  start-page: 5088
  year: 2005
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib12
  article-title: Predictors of endothelial dysfunction in young women with polycystic ovary
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-0151
– volume: 28
  start-page: 412
  year: 1985
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib27
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 22
  start-page: 147
  year: 2002
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib24
  article-title: Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/hq0102.101770
– volume: 66
  start-page: 942
  year: 1996
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib4
  article-title: Hyperinsulinemia is common in family members of women with polycystic ovary syndrome
  publication-title: Fertil Steril
  doi: 10.1016/S0015-0282(16)58687-7
– volume: 89
  start-page: 4588
  year: 2004
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib10
  article-title: Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-031867
– volume: 24
  start-page: 302
  year: 2003
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib39
  article-title: Polycystic ovary syndrome and cardiovascular disease: a premature association?
  publication-title: Endocr Rev
  doi: 10.1210/er.2003-0004
– volume: 93
  start-page: 82
  year: 2008
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib14
  article-title: Asymmetric dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-0842
– volume: 36
  start-page: 691
  year: 2006
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib31
  article-title: Inflammatory and endothelial markers in women with polycystic ovary syndrome
  publication-title: Eur J Clin Invest
  doi: 10.1111/j.1365-2362.2006.01712.x
– volume: 90
  start-page: 1929
  year: 2005
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib6
  article-title: Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-1045
– volume: 116
  start-page: 287
  year: 2007
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib16
  article-title: Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2007.06.012
– volume: 58
  start-page: 151
  year: 2005
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib34
  article-title: Cardiovascular risk in women with polycystic ovary syndrome (PCOS)
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.2003.015271
– volume: 25
  start-page: 2661
  year: 2005
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib18
  article-title: Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000193622.77294.57
– volume: 65
  start-page: 655
  year: 2006
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib32
  article-title: Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2006.02645.x
– volume: 66
  start-page: 545
  year: 1985
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib5
  article-title: Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization
  publication-title: Obstet Gynecol
– volume: 105
  start-page: 299
  year: 1984
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib22
  article-title: Comparative studies on different methods of malonaldehyde determination
  publication-title: Methods Enzymol
  doi: 10.1016/S0076-6879(84)05038-2
– volume: 103
  start-page: 1410
  year: 2001
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib9
  article-title: Polycystic ovary syndrome is associated with endothelial dysfunction
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.10.1410
– volume: 85
  start-page: 1851
  year: 2000
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib33
  article-title: Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.85.5.1851
– volume: 60
  start-page: 180
  year: 2005
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib11
  article-title: Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation
  publication-title: Obstet Gynecol Surv
  doi: 10.1097/01.ogx.0000156089.26363.5b
– volume: 16
  start-page: 2606
  year: 2001
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib2
  article-title: Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment
  publication-title: Hum Reprod
  doi: 10.1093/humrep/16.12.2606
– volume: 102
  start-page: 2810
  year: 2000
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib36
  article-title: Nitroglycerin tolerance in human vessels. Evidence for impaired nitroglycerin bioconversion
  publication-title: Circulation
  doi: 10.1161/01.CIR.102.23.2810
– volume: 13
  start-page: 323
  year: 2001
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib8
  article-title: Obesity, polycystic ovary syndrome and anovulation—how are they interrelated?
  publication-title: Curr Opin Obstet Gynecol
  doi: 10.1097/00001703-200106000-00013
– volume: 37
  start-page: 1851
  year: 2001
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib29
  article-title: Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(01)01238-4
– volume: 100
  start-page: 129
  year: 1999
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib23
  article-title: Nitrate resistance in platelets from patients with stable angina pectoris
  publication-title: Circulation
  doi: 10.1161/01.CIR.100.2.129
– volume: 40
  start-page: 521
  year: 2002
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib25
  article-title: Assessment of endothelial function using peripheral waveform analysis: a clinical application
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(02)01991-5
– volume: 101
  start-page: 1899
  year: 2000
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib17
  article-title: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.16.1899
– volume: 113
  start-page: 1308
  year: 2006
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib35
  article-title: Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome
  publication-title: BJOG
  doi: 10.1111/j.1471-0528.2006.01090.x
– volume: 109
  start-page: 433
  year: 2004
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib26
  article-title: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000111245.75752.C6
– volume: 9
  start-page: 125
  year: 2004
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib21
  article-title: Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues
  publication-title: Redox Rep
  doi: 10.1179/135100004225005219
– volume: 352
  start-page: 1223
  year: 2005
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib1
  article-title: Polycystic ovary syndrome
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra041536
– volume: 49
  start-page: 304
  year: 2007
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib30
  article-title: The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes. Mediation by superoxide production, resolution with intensive insulin administration
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.08.053
– volume: 46
  start-page: 1693
  year: 2005
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib37
  article-title: Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2005.04.066
– volume: 102
  start-page: 565
  year: 2007
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib38
  article-title: Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease
  publication-title: Basic Res Cardiol
  doi: 10.1007/s00395-007-0680-1
– volume: 84
  start-page: 165
  year: 1999
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib7
  article-title: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.84.1.165
– volume: 805
  start-page: 325
  year: 2004
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib19
  article-title: Determination of l-arginine and NG,NG- and NG,NG’-dimethyl-l-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives
  publication-title: J Chromatogr B
  doi: 10.1016/j.jchromb.2004.03.020
– volume: 85
  start-page: 2402
  year: 2000
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib28
  article-title: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.85.7.2402
– volume: 88
  start-page: 2263
  year: 2003
  ident: 10.1016/j.atherosclerosis.2008.09.010_bib15
  article-title: Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2002-021391
SSID ssj0004718
Score 2.2594285
Snippet Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary risk...
Abstract Platelet hyporesponsiveness to the anti-aggregatory effects of nitric oxide (NO) occurs commonly in association with myocardial ischemia and coronary...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 509
SubjectTerms Adenosine Diphosphate
Adult
Albuterol - pharmacology
Arginine - analogs & derivatives
Arginine - blood
Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Blood and lymphatic vessels
Blood coagulation. Blood cells
Body Composition
C-Reactive Protein - metabolism
Cardiology. Vascular system
Cardiovascular
Cohort Studies
Endothelial Cells - pathology
Endothelial function
Endothelium, Vascular - drug effects
Endothelium, Vascular - metabolism
Endothelium, Vascular - pathology
Endothelium, Vascular - physiopathology
Female
Fundamental and applied biological sciences. Psychology
Humans
Inflammation Mediators - blood
Malondialdehyde - blood
Medical sciences
Molecular and cellular biology
Nitric oxide
Nitric Oxide - blood
Nitric Oxide Donors - pharmacology
Nitroglycerin - pharmacology
Nitroprusside - pharmacology
Obesity - blood
Obesity - complications
Obesity - physiopathology
Oxidative Stress
Platelet
Platelet Aggregation - drug effects
Platelet Function Tests
Platelets
Polycystic ovary syndrome
Polycystic Ovary Syndrome - blood
Polycystic Ovary Syndrome - complications
Polycystic Ovary Syndrome - physiopathology
Stem Cells - pathology
Time Factors
Vasodilator Agents - pharmacology
Title Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0021915008006291
https://www.clinicalkey.es/playcontent/1-s2.0-S0021915008006291
https://dx.doi.org/10.1016/j.atherosclerosis.2008.09.010
https://www.ncbi.nlm.nih.gov/pubmed/19027116
https://www.proquest.com/docview/67295497
Volume 204
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: ACRLP
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: AIKHN
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: AKRWK
  dateStart: 19700101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEA_HCYcg4rf1Y82DPvauH2myBRGPw2NV7vDBg3sLaTOBldIum11xX_zbnWnTXU5POPGlD2mSpjOTyY_MF2OvS6MMOOvixCQ2FpDingM5jRGbSlEaoRJLFt2zczm7EJ8ui8s9djLGwpBbZdD9g07vtXVoOQrUPFrM5xTji7sN8QxhHpkNEexCklvf4c-dmwcp38HNI42p9wF7s_Px6kFW53FKfM59cK0sDxMKqL3-nLqzMB6p54ayF3_Hpf35dHqP3Q3Akh8Pa7_P9qB9wA7Ogun8IfvxpWs29YbSMvPuu1lu-JisgM89N4FLYDndzHJcByyBLxpsQs5y01oOraVwrQYlltuNpxORuMrnLa_wBe8q8ND3bMC03K8ruuPxj9jF6YevJ7M4lF2I6yIXq9jkSDLInUtdYQqTugpkVZZOISNrUcmcAq5BlMokwlGCOgQtVVWkclpP7dSp_DHbb7sWnjKeFg4BkCycqh2yPTWoX60Cm-dZ4ayAiL0diazrkJOcSmM0enQ--6Z_41Gom1lq5FHE5Hb4YkjOcdOB70aO6jECFXWmxmPkphOo6yYAHzSA16n2mU70H1IasffbkVcE_V8-PrkihNt_zxBcU_6hiL0apVKjtiATkGmhW3stVW_XVRF7Mgjrjm5lkqk0lc_-f33P2e3B5kZ3VS_Y_mq5hpcI3VbVpN-bE3br-OPn2fkvKTFJuA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBZhA2mhlL7rPhId2qMbyw9pDaU0hIZNk116SCA3IVsjcDH2stoN2X_fkS3vkjaFlF58sC1Znhl9-tA8RMiHXAkFRpswUpEOU2A454CPQ-SmPM1VKiLtPLrTGZ9cpt-vsqsdcjzkwriwSo_9PaZ3aO3vHHppHs6ryuX44mxDPuM4D49dBvtumiEmj8ju0enZZLZNjxSsB2QXjYAN9sjHbZhXx7Nai73itbI-ujL_FLmc2ruXqkdzZVGApj_54u_UtFuiTp6Qx55b0qN--E_JDjTPyN7Ue8-fk5sfbb0u164yM22v1WJNh3oFtLJUeUWBpm5zluI4YAF0XuMtVC5VjabQaJexVaPRUr22blF0iqVVQwt8QNsCLHRv1qAaaleF2-axL8jlybeL40noT14IyyxJl6FKUGSQGMNMpjLFTAG8yHMjUJdlWvDE5VxDmgsVpcbVqEPeUhQZ4-NyrMdGJC_JqGkbeE0oywxyIJ4ZURrUPFMIsVqATpI4MzqFgHwehCxLX5bcnY5RyyH-7Kf8TUf-6Mxcoo4CwjfN5319jvs2_DJoVA5JqAibEleS-3Yg7uoArAcBK5m0sYzkH4YakK-blrds_V8-vn_LCDf_HiO_diWIAnIwWKVEwHBeINVAu7KSi861KwLyqjfWrdzyKBaM8Tf_P74D8mByMT2X56ezs7fkYe-Cc1tX78houVjBe2Ryy2Lfz9RfKIxMYw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polycystic+ovary+syndrome+is+associated+with+severe+platelet+and+endothelial+dysfunction+in+both+obese+and+lean+subjects&rft.jtitle=Atherosclerosis&rft.au=Rajendran%2C+Sharmalar&rft.au=Willoughby%2C+Scott+R.&rft.au=Chan%2C+Wai+Ping+A.&rft.au=Liberts%2C+Elizabeth+A.&rft.date=2009-06-01&rft.pub=Elsevier+Ireland+Ltd&rft.issn=0021-9150&rft.volume=204&rft.issue=2&rft.spage=509&rft.epage=514&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2008.09.010&rft.externalDocID=S0021915008006291
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00219150%2FS0021915009X00067%2Fcov150h.gif